Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew

Pharmacology Biochemistry and Behavior

Volumn 69, Issue 1-2, 2001, Pages 239-249

  Darmani, Nissar A ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

9 THC; Antiemetic; CB1 receptor; CB2 receptor; Cisplatin; Emesis; Locomotor activity; Rearing; SR 141716A; SR 144528

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CISPLATIN; DRONABINOL; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIEMETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; FEMALE; IC 50; INSECTIVORE; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; VOMITING;

ANIMALS; ANTIEMETICS; ANTINEOPLASTIC AGENTS; BORNANES; CISPLATIN; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SHREWS; TETRAHYDROCANNABINOL; VOMITING;

EID: 0034989972     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00531-7     Document Type: Article

References (62)

1. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid
2. Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa
3. Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate
4. Cannabinoid modulation of intestinal propulsion in mice
5. In vivo characterization of a specific cannabinoid receptor antagonist (SR 141716A). Inhibition of (9-tetrahydrocannabinol-induced responses and apparent agonist activity
6. Potential role of cannabinoids for therapy of neurologic disorders
7. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: A new experimental model of emesis
8. 1 receptor antagonist/inverse agonist SR 141716A
9. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)
10. Marihuana on locomotor activity: Biphasic effect and tolerance development
11. 3 agent N-(3-chlorphenyl) guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew model of emesis
12. Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid
13. Cannabimimetic activity in rats and pigeons of HU 210, a potent antiemetic drug
14. The medicinal uses of cannabis and its constituents
15. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving chemotherapy: A comparison with prochlorperazine and placebo
16. The motivation for beer in rats: Effects of ritanserin, naloxone and SR 141716A
17. Two-pronged study of tetrahydrocannabinol (THC) prevention of vomiting from cancer chemotherapy
18. Cannabinoids and the control of chemotherapy-induced nausea and vomiting
19. Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol
20. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
21. 1 receptors
22. Animal models in the study of vomiting
23. Drug effects on active immobility responses: What they tell us about neurotransmitter systems and motor functions
24. 1 receptors
25. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy
26. Suppression of cancer chemotherapy-induced vomiting in the cat by nabilone, a synthetic cannabinoid
27. Studies on the pharmacology and acute toxicity of compounds with marihuana activity
28. 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy
29. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
30. Structural requirements for cannabinoid receptor probes
31. SR 141716A, a CB1 cannabinoid antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine
32. Molecular aspects of cannabinoid receptors
33. Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: A new experimental model
34. Cannabinoids and appetite stimulation
35. Antiemetic activity of N-methyllevonantradol and nabilone in cisplatin-treated cats
36. Antiemetic properties and plasma concentrations of delta-9-tetrahydrocannabinol against cisplatin vomiting in cats
37. Pharmacological agents affecting emesis: A review (part 1)
38. Comparative trial of the antiemetic effects of THC and haloperidol
39. The analgesic properties of delta-9-tetrahydrocannabinol and codeine
40. Cannabinoid receptor genes
41. 9-tetrahydrocannabinol in chemotherapy-associated nausea and vomiting as compared to placebo and compazine
42. 2 receptors
43. 1) receptors by SR 141716A selectively antagonizes drug-induced reinstatement of exploratory behavior in gerbils
44. Marijuana: A research overview
45. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
46. 2 cannabinoid receptor
47. 1 receptor ligand
48. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy
49. Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine
50. Motor actions of cannabinoids in the basal ganglia output nuclei
51. Activational role of cannabinoids on movement
52. 9-tetrahydrocannabinol in apomorphine-induced emesis in the dog
53. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents
54. Interaction of NMDA and AP5 and the ACTH (4-9) analog Org 2766 on spatial orientation and locomotor activity
55. The pharmacologic profile of nabilone: A new antiemetic agent
56. Biphasic effects of anandamide
57. 9-Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy: A pilot study
58. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
59. Medicinal application of delta-9-tetrahydrocannabinol and marijuana
60. Spontaneous motor activity in Arctic Charr measured by a computerized imaging technique: Role of brain serotonergic activity
61. Clobenzorex: Evidence for amphetamine-like behavioral actions